Sara Ward

Sara Ward

Company: Temple University

Job title: Researcher – Oncology


Dr. Ward’s research interests focus on the therapeutic potential of non-psychoactive cannabinoid compounds for the treatment of nervous system disorders, including neuropathic pain, neuroinflammation, and substance abuse. There are two ongoing projects investigating cannabinoid effects on neuropathic pain. The goal of these projects is to elucidate the therapeutic mechanisms by which the non-psychoactive cannabinoid, cannabidiol, protects against the development of neuropathic pain. Dr. Ward’s laboratory uses two mouse models of neuropathic pain 1) a central model of spinal cord injury and 2) a peripheral model of chemotherapy-induced neuropathic pain. The therapeutic strategy includes understanding the neuroprotective mechanisms of cannabidiol alone and in combination with the psychoactive phytocannabinoid, D9-tetrahydrocannabinol (D9-THC) and other minor phytocannabinoids.

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.